China
Africa
Explore chapters and articles related to this topic
Strongyloidiasis
Published in Peter D. Walzer, Robert M. Genta, Parasitic Infections in the Compromised Host, 2020
Robert M. Genta, Peter D. Walzer
The pathological lesions specifically associated with chronic, uncomplicated S. stercoralis infections in otherwise healthy hosts are little known, because only rarely have such cases come to autopsy. However, a few patients in whom strongyloidiasis was an incidental finding have been reported, and the pathological descriptions of these cases indicate that the worms can exist within the intestinal mucosa without causing significant inflammatory responses or other tissue damage. The examination of two such cases as early as 1886 led Golgi and Monti to declare that the Anguillula intestinalis (as S. stercoralis was known then) was an "innocent inhabitant of the human intestine" (116). This concept became so well established that in some European countries strongyloidiasis is still known by the deceptive term "benign ancylostomiasis."
Limbs
Published in Keith Hopcroft, Vincent Forte, Symptom Sorter, 2020
RARE malnutritioninferior vena cava thrombosisfilariasisMilroy’s disease (hereditary lymphoedema)ancylostomiasis (hookworm)angioneurotic oedema
Ethnobotanical Survey for Managing Selected Non-Communicable Diseases
Published in Hafiz Ansar Rasul Suleria, Megh R. Goyal, Masood Sadiq Butt, Phytochemicals from Medicinal Plants, 2019
Godwin Ojochogu Adejo, Sunday Ene-Ojo Atawodi, Kingsley Okoyomoh
Paullinia pinnata has been used traditionally as remedy for different forms of pains.35 The leaves are used in East African regions against mental problems, eye troubles and blindness, snakebites, and rabies. Extracts of a combination of the leaves and the roots are potent against malaria, ancylostomiasis, gonorrhea, paralysis, wounds, threatened abortion, and placenta expulsion during childbirth. The roots of P. pinnata have been used as a tonic and styptic medicine and to treat eczema. The processed whole plant is used to treat bad skin conditions, microbial infections and wounds.35 The root decoction is used as antidote to nausea and vomiting.35
Fifty years after the eradication of Malaria in Italy. The long pathway toward this great goal and the current health risks of imported malaria
Published in Pathogens and Global Health, 2021
Mariano Martini, Andrea Angheben, Niccolò Riccardi, Davide Orsini
After the discovery of the insecticidal action of ‘Paris Green’ against the larvae of the Anopheles mosquito, in 1923 the League of Nations promoted an investigation on malaria endemicity in Europe and the use of quinine. Thus, the Rockefeller Foundation in New York launched a program of cooperation in Italy under the direction of Lewis Wendell Hackett, a public health doctor with previous experience in ancylostomiasis control in Central America. Collaboration with Alberto Missiroli led to the foundation of the Stazione Sperimentale per la Lotta Antimalarica (The Experimental Station for Malaria Control) in Italy, which played a major role in staff training and updating on the most advanced techniques of malariology. In 1925, Paris Green was tested as an anti-larval agent in several malarial zones in central and southern Italy, with good results in small urban centers.